University of Buffalo Commences Sarilumab Clinical Trial for those COVID-19 Patients at Risk for Cytokine Storm

University of Buffalo Commences Sarilumab Clinical Trial for those COVID-19 Patients at Risk for Cytokine Storm

University of Buffalo (UB) and Roswell Park Comprehensive Cancer Center received the greenlight from the U.S. Food and Drug Administration to initial a “collaborative clinical study” using sarilumab to address some adverse COVID-19 effects.  The study’s principal...
Regeneron Leverages its Technology Platform, Process and People in the Hopes of Having A COVID-19 Therapy in Trials by Summer

Regeneron Leverages its Technology Platform, Process and People in the Hopes of Having A COVID-19 Therapy in Trials by Summer

Regeneron and its “VELOCISUITE®” platform was used to develop a treatment for Ebola (REGN-EB3), currently used by the Congolese government to fight that horrific virus. The New York State-based venture has, like many biopharma companies, dedicated a full force...

Pin It on Pinterest